ZALANDO SE (ZAL.DE) Stock Fundamental Analysis

FRA:ZAL • DE000ZAL1111

20.25 EUR
+0.08 (+0.4%)
Last: Feb 24, 2026, 12:32 PM
Overview Stock Chart Technical Analysis Fundamental Analysis Analyst Ratings Earnings Estimates Financials Ownership
Fundamental Rating

5

Taking everything into account, ZAL scores 5 out of 10 in our fundamental rating. ZAL was compared to 56 industry peers in the Specialty Retail industry. Both the profitability and the financial health of ZAL get a neutral evaluation. Nothing too spectacular is happening here. ZAL is not priced too expensively while it is growing strongly. Keep and eye on this one! This makes ZAL very considerable for growth investing!


Dividend Valuation Growth Profitability Health

6

1. Profitability

1.1 Basic Checks

  • In the past year ZAL was profitable.
  • In the past year ZAL had a positive cash flow from operations.
  • Each year in the past 5 years ZAL has been profitable.
  • Each year in the past 5 years ZAL had a positive operating cash flow.
ZAL.DE Yearly Net Income VS EBIT VS OCF VS FCFZAL.DE Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 200M 400M 600M 800M

1.2 Ratios

  • ZAL has a Return On Assets of 2.66%. This is comparable to the rest of the industry: ZAL outperforms 58.93% of its industry peers.
  • ZAL has a Return On Equity of 8.44%. This is in the better half of the industry: ZAL outperforms 66.07% of its industry peers.
  • Looking at the Return On Invested Capital, with a value of 5.47%, ZAL is in line with its industry, outperforming 58.93% of the companies in the same industry.
  • Measured over the past 3 years, the Average Return On Invested Capital for ZAL is significantly below the industry average of 9.76%.
  • The 3 year average ROIC (3.34%) for ZAL is below the current ROIC(5.47%), indicating increased profibility in the last year.
Industry RankSector Rank
ROA 2.66%
ROE 8.44%
ROIC 5.47%
ROA(3y)1.48%
ROA(5y)2.26%
ROE(3y)4.56%
ROE(5y)6.95%
ROIC(3y)3.34%
ROIC(5y)4.59%
ZAL.DE Yearly ROA, ROE, ROICZAL.DE Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 2 4 6 8 10

1.3 Margins

  • Looking at the Profit Margin, with a value of 2.06%, ZAL is in the better half of the industry, outperforming 62.50% of the companies in the same industry.
  • ZAL's Profit Margin has improved in the last couple of years.
  • With a Operating Margin value of 3.30%, ZAL perfoms like the industry average, outperforming 53.57% of the companies in the same industry.
  • In the last couple of years the Operating Margin of ZAL has grown nicely.
  • With a decent Gross Margin value of 40.37%, ZAL is doing good in the industry, outperforming 60.71% of the companies in the same industry.
  • In the last couple of years the Gross Margin of ZAL has remained more or less at the same level.
Industry RankSector Rank
OM 3.3%
PM (TTM) 2.06%
GM 40.37%
OM growth 3Y-2.26%
OM growth 5Y7.72%
PM growth 3Y1.6%
PM growth 5Y9.08%
GM growth 3Y-0.88%
GM growth 5Y-0.89%
ZAL.DE Yearly Profit, Operating, Gross MarginsZAL.DE Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 10 20 30 40

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

5

2. Health

2.1 Basic Checks

  • With a Return on Invested Capital (ROIC) below the Cost of Capital (WACC), ZAL is destroying value.
  • Compared to 1 year ago, ZAL has less shares outstanding
  • ZAL has more shares outstanding than it did 5 years ago.
  • ZAL has a better debt/assets ratio than last year.
ZAL.DE Yearly Shares OutstandingZAL.DE Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 50M 100M 150M 200M 250M
ZAL.DE Yearly Total Debt VS Total AssetsZAL.DE Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 2B 4B 6B

2.2 Solvency

  • An Altman-Z score of 2.21 indicates that ZAL is not a great score, but indicates only limited risk for bankruptcy at the moment.
  • ZAL has a Altman-Z score (2.21) which is in line with its industry peers.
  • The Debt to FCF ratio of ZAL is 3.63, which is a good value as it means it would take ZAL, 3.63 years of fcf income to pay off all of its debts.
  • Looking at the Debt to FCF ratio, with a value of 3.63, ZAL is in the better half of the industry, outperforming 69.64% of the companies in the same industry.
  • ZAL has a Debt/Equity ratio of 0.44. This is a healthy value indicating a solid balance between debt and equity.
  • ZAL has a better Debt to Equity ratio (0.44) than 64.29% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.44
Debt/FCF 3.63
Altman-Z 2.21
ROIC/WACC0.89
WACC6.18%
ZAL.DE Yearly LT Debt VS Equity VS FCFZAL.DE Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 500M 1B 1.5B 2B 2.5B

2.3 Liquidity

  • ZAL has a Current Ratio of 1.12. This is a normal value and indicates that ZAL is financially healthy and should not expect problems in meeting its short term obligations.
  • With a Current ratio value of 1.12, ZAL perfoms like the industry average, outperforming 42.86% of the companies in the same industry.
  • ZAL has a Quick Ratio of 1.12. This is a bad value and indicates that ZAL is not financially healthy enough and could expect problems in meeting its short term obligations.
  • With a Quick ratio value of 0.59, ZAL perfoms like the industry average, outperforming 55.36% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 1.12
Quick Ratio 0.59
ZAL.DE Yearly Current Assets VS Current LiabilitesZAL.DE Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 1B 2B 3B 4B 5B

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

7

3. Growth

3.1 Past

  • ZAL shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 17.72%, which is quite good.
  • The Earnings Per Share has been growing by 23.33% on average over the past years. This is a very strong growth
  • ZAL shows quite a strong growth in Revenue. In the last year, the Revenue has grown by 12.06%.
  • The Revenue has been growing by 10.28% on average over the past years. This is quite good.
EPS 1Y (TTM)17.72%
EPS 3Y2.91%
EPS 5Y23.33%
EPS Q2Q%-64.71%
Revenue 1Y (TTM)12.06%
Revenue growth 3Y0.7%
Revenue growth 5Y10.28%
Sales Q2Q%26.46%

3.2 Future

  • Based on estimates for the next years, ZAL will show a very strong growth in Earnings Per Share. The EPS will grow by 27.45% on average per year.
  • The Revenue is expected to grow by 9.99% on average over the next years. This is quite good.
EPS Next Y19.08%
EPS Next 2Y24.54%
EPS Next 3Y25.18%
EPS Next 5Y27.45%
Revenue Next Year17.17%
Revenue Next 2Y15.4%
Revenue Next 3Y12.21%
Revenue Next 5Y9.99%

3.3 Evolution

  • The EPS growth rate is stable: in the next years the growth will be about the same than in the last years.
  • When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is stable.
ZAL.DE Yearly Revenue VS EstimatesZAL.DE Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2017 2019 2021 2023 2025 2027 2029 2031 2033 5B 10B 15B 20B
ZAL.DE Yearly EPS VS EstimatesZAL.DE Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2017 2019 2021 2023 2025 2027 2029 2031 2033 1 2 3 4

More info and screens

Find the best growth stocksShow best growing peers

5

4. Valuation

4.1 Price/Earnings Ratio

  • ZAL is valuated rather expensively with a Price/Earnings ratio of 21.77.
  • ZAL's Price/Earnings ratio is a bit cheaper when compared to the industry. ZAL is cheaper than 67.86% of the companies in the same industry.
  • ZAL's Price/Earnings ratio indicates a similar valuation than the S&P500 average which is at 26.64.
  • The Price/Forward Earnings ratio is 13.46, which indicates a correct valuation of ZAL.
  • Compared to the rest of the industry, the Price/Forward Earnings ratio of ZAL indicates a somewhat cheap valuation: ZAL is cheaper than 71.43% of the companies listed in the same industry.
  • The average S&P500 Price/Forward Earnings ratio is at 27.75. ZAL is valued rather cheaply when compared to this.
Industry RankSector Rank
PE 21.77
Fwd PE 13.46
ZAL.DE Price Earnings VS Forward Price EarningsZAL.DE Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 5 10 15 20 25

4.2 Price Multiples

  • Based on the Enterprise Value to EBITDA ratio, ZAL is valued a bit cheaper than 64.29% of the companies in the same industry.
  • ZAL's Price/Free Cash Flow is on the same level as the industry average.
Industry RankSector Rank
P/FCF 13.47
EV/EBITDA 6.8
ZAL.DE Per share dataZAL.DE EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 10 20 30 40

4.3 Compensation for Growth

  • ZAL's PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a correct valuation of the company.
  • The decent profitability rating of ZAL may justify a higher PE ratio.
  • A more expensive valuation may be justified as ZAL's earnings are expected to grow with 25.18% in the coming years.
PEG (NY)1.14
PEG (5Y)0.93
EPS Next 2Y24.54%
EPS Next 3Y25.18%

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

0

5. Dividend

5.1 Amount

  • No dividends for ZAL!.
Industry RankSector Rank
Dividend Yield 0%

More info and screens

Find the best dividend stocksShow peers with best dividend

ZALANDO SE

FRA:ZAL (2/24/2026, 12:32:04 PM)

20.25

+0.08 (+0.4%)

Chartmill FA Rating
GICS IndustryGroupConsumer Discretionary Distribution & Retail
GICS IndustrySpecialty Retail
Earnings (Last)11-06
Earnings (Next)03-12
Inst Owners60.67%
Inst Owner ChangeN/A
Ins Owners10.12%
Ins Owner ChangeN/A
Market Cap5.35B
Revenue(TTM)11.57B
Net Income(TTM)239.00M
Analysts80
Price Target36.87 (82.07%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)0
Avg EPS beat(2)-32.59%
Min EPS beat(2)-62.87%
Max EPS beat(2)-2.31%
EPS beat(4)2
Avg EPS beat(4)210.92%
Min EPS beat(4)-62.87%
Max EPS beat(4)892.08%
EPS beat(8)4
Avg EPS beat(8)93.43%
EPS beat(12)6
Avg EPS beat(12)41.34%
EPS beat(16)7
Avg EPS beat(16)-15.84%
Revenue beat(2)1
Avg Revenue beat(2)1.48%
Min Revenue beat(2)-0.03%
Max Revenue beat(2)2.99%
Revenue beat(4)3
Avg Revenue beat(4)1.29%
Min Revenue beat(4)-0.03%
Max Revenue beat(4)2.99%
Revenue beat(8)4
Avg Revenue beat(8)0.09%
Revenue beat(12)5
Avg Revenue beat(12)-0.24%
Revenue beat(16)5
Avg Revenue beat(16)-0.64%
PT rev (1m)-0.56%
PT rev (3m)0.51%
EPS NQ rev (1m)8.06%
EPS NQ rev (3m)14.2%
EPS NY rev (1m)0%
EPS NY rev (3m)-2.96%
Revenue NQ rev (1m)0.22%
Revenue NQ rev (3m)0.32%
Revenue NY rev (1m)0.4%
Revenue NY rev (3m)1.27%
Valuation
Industry RankSector Rank
PE 21.77
Fwd PE 13.46
P/S 0.46
P/FCF 13.47
P/OCF 8.76
P/B 1.89
P/tB 4.36
EV/EBITDA 6.8
EPS(TTM)0.93
EY4.59%
EPS(NY)1.5
Fwd EY7.43%
FCF(TTM)1.5
FCFY7.42%
OCF(TTM)2.31
OCFY11.42%
SpS43.81
BVpS10.72
TBVpS4.65
PEG (NY)1.14
PEG (5Y)0.93
Graham Number14.98
Profitability
Industry RankSector Rank
ROA 2.66%
ROE 8.44%
ROCE 8.93%
ROIC 5.47%
ROICexc 8.23%
ROICexgc 18.89%
OM 3.3%
PM (TTM) 2.06%
GM 40.37%
FCFM 3.43%
ROA(3y)1.48%
ROA(5y)2.26%
ROE(3y)4.56%
ROE(5y)6.95%
ROIC(3y)3.34%
ROIC(5y)4.59%
ROICexc(3y)9.52%
ROICexc(5y)14.27%
ROICexgc(3y)13.4%
ROICexgc(5y)19.23%
ROCE(3y)5.45%
ROCE(5y)7.5%
ROICexgc growth 3Y8.96%
ROICexgc growth 5Y22.36%
ROICexc growth 3Y2.72%
ROICexc growth 5Y17.49%
OM growth 3Y-2.26%
OM growth 5Y7.72%
PM growth 3Y1.6%
PM growth 5Y9.08%
GM growth 3Y-0.88%
GM growth 5Y-0.89%
F-Score7
Asset Turnover1.29
Health
Industry RankSector Rank
Debt/Equity 0.44
Debt/FCF 3.63
Debt/EBITDA 1.61
Cap/Depr 55.55%
Cap/Sales 1.85%
Interest Coverage 250
Cash Conversion 79.63%
Profit Quality 166.19%
Current Ratio 1.12
Quick Ratio 0.59
Altman-Z 2.21
F-Score7
WACC6.18%
ROIC/WACC0.89
Cap/Depr(3y)86.74%
Cap/Depr(5y)104.05%
Cap/Sales(3y)2.65%
Cap/Sales(5y)2.86%
Profit Quality(3y)549.88%
Profit Quality(5y)378.62%
High Growth Momentum
Growth
EPS 1Y (TTM)17.72%
EPS 3Y2.91%
EPS 5Y23.33%
EPS Q2Q%-64.71%
EPS Next Y19.08%
EPS Next 2Y24.54%
EPS Next 3Y25.18%
EPS Next 5Y27.45%
Revenue 1Y (TTM)12.06%
Revenue growth 3Y0.7%
Revenue growth 5Y10.28%
Sales Q2Q%26.46%
Revenue Next Year17.17%
Revenue Next 2Y15.4%
Revenue Next 3Y12.21%
Revenue Next 5Y9.99%
EBIT growth 1Y2.33%
EBIT growth 3Y-1.58%
EBIT growth 5Y18.79%
EBIT Next Year118.78%
EBIT Next 3Y43.23%
EBIT Next 5Y33.06%
FCF growth 1Y-18.24%
FCF growth 3Y16.44%
FCF growth 5Y84.9%
OCF growth 1Y-20.35%
OCF growth 3Y2.01%
OCF growth 5Y14.86%

ZALANDO SE / ZAL.DE FAQ

Can you provide the ChartMill fundamental rating for ZALANDO SE?

ChartMill assigns a fundamental rating of 5 / 10 to ZAL.DE.


Can you provide the valuation status for ZALANDO SE?

ChartMill assigns a valuation rating of 5 / 10 to ZALANDO SE (ZAL.DE). This can be considered as Fairly Valued.


Can you provide the profitability details for ZALANDO SE?

ZALANDO SE (ZAL.DE) has a profitability rating of 6 / 10.


What is the valuation of ZALANDO SE based on its PE and PB ratios?

The Price/Earnings (PE) ratio for ZALANDO SE (ZAL.DE) is 21.77 and the Price/Book (PB) ratio is 1.89.


What is the financial health of ZALANDO SE (ZAL.DE) stock?

The financial health rating of ZALANDO SE (ZAL.DE) is 5 / 10.